TScan Therapeutics (TCRX) Other Non-Current Assets (2020 - 2025)
Historic Other Non-Current Assets for TScan Therapeutics (TCRX) over the last 6 years, with Q3 2025 value amounting to $5.0 million.
- TScan Therapeutics' Other Non-Current Assets changed 0.0% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $5.0 million for FY2024, which is 0.0% changed from last year.
- According to the latest figures from Q3 2025, TScan Therapeutics' Other Non-Current Assets is $5.0 million, which was down 0.0% from $5.0 million recorded in Q2 2025.
- Over the past 5 years, TScan Therapeutics' Other Non-Current Assets peaked at $5.0 million during Q2 2022, and registered a low of $595000.0 during Q1 2021.
- Over the past 5 years, TScan Therapeutics' median Other Non-Current Assets value was $5.0 million (recorded in 2021), while the average stood at $4.3 million.
- In the last 5 years, TScan Therapeutics' Other Non-Current Assets skyrocketed by 74655.46% in 2022 and then fell by 11.91% in 2023.
- TScan Therapeutics' Other Non-Current Assets (Quarter) stood at $5.0 million in 2021, then grew by 0.12% to $5.0 million in 2022, then fell by 0.12% to $5.0 million in 2023, then changed by 0.0% to $5.0 million in 2024, then changed by 0.0% to $5.0 million in 2025.
- Its Other Non-Current Assets stands at $5.0 million for Q3 2025, versus $5.0 million for Q2 2025 and $5.0 million for Q1 2025.